Lena M. Mattes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Lena M. Mattes has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Bernhard G. Weiss
Department for Otorhinolaryngology, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany
1 shared publication Frank Haubner
Department of Otorhinolaryngology University Hospital, LMU Munich Munich Germany
1 shared publicationFriedrich Ihler
Department of Otorhinolaryngology University Hospital, LMU Munich Munich Germany
1 shared publication- Jennifer Lee Spiegel
Department of Otolaryngology Head and Neck Surgery Sunnybrook Health Sciences Centre, University of Toronto Toronto Ontario Canada
1 shared publication Julia Hess
Research Unit Radiation Cytogenetics, Helmholtz Zentrum München Research Center for Environmental Health (GmbH) Munich Germany
1 shared publicationJulia Kitz
Institute of Pathology University Medical Center Göttingen, Georg‐August‐Universität Göttingen Göttingen Germany
1 shared publication
Latest Publications
- 29 September 2021
- Published by Wiley in Head & Neck
- Vol. 43 (12) , 3707-3719
Human microRNA ‐182‐5p and kinectin 1: Potential biomarkers for prognosis in oral squamous cell carcinoma
Background The prognostic impact of hsa-miRNA-182-5p in oral cancer remains unexplored. Therefore, the aim of this study was to investigate the prognostic value of hsa-miRNA-182-5p and its predicted target kinectin 1 (KTN1) in oral squamous cell carcinoma (OSCC). Method Expression level of hsa-miRNA-182-5p was analyzed in tumor tissue (n = 36) and healthy oral mucosal tissue (n = 17) using quantitative real-time polymerase chain reaction. Protein level of the predicted target KTN1 was detected via immunohistochemistry. Results were validated in a cohort of The Cancer Genome Atlas (TCGA). Results After dividing the data into a subgroup with high and low hsa-miRNA-182-5p expression level, a significant better overall (p = 0.016), recurrence-free (p = 0.009), and progression-free survival (p = 0.004) was observed in an upregulation of hsa-miRNA-182-5p. Staining intensity of KTN1 showed a reciprocal impact on the prognosis. Validation in a TCGA cohort confirmed these results. Conclusion Our results indicate hsa-miRNA-182-5p and KTN1 as potential biomarkers for OSCC.
- 29 September 2021
- Published by Wiley in Head & Neck
- Vol. 43 (12) , 3707-3719
Human microRNA ‐182‐5p and kinectin 1: Potential biomarkers for prognosis in oral squamous cell carcinoma
Background The prognostic impact of hsa-miRNA-182-5p in oral cancer remains unexplored. Therefore, the aim of this study was to investigate the prognostic value of hsa-miRNA-182-5p and its predicted target kinectin 1 (KTN1) in oral squamous cell carcinoma (OSCC). Method Expression level of hsa-miRNA-182-5p was analyzed in tumor tissue (n = 36) and healthy oral mucosal tissue (n = 17) using quantitative real-time polymerase chain reaction. Protein level of the predicted target KTN1 was detected via immunohistochemistry. Results were validated in a cohort of The Cancer Genome Atlas (TCGA). Results After dividing the data into a subgroup with high and low hsa-miRNA-182-5p expression level, a significant better overall (p = 0.016), recurrence-free (p = 0.009), and progression-free survival (p = 0.004) was observed in an upregulation of hsa-miRNA-182-5p. Staining intensity of KTN1 showed a reciprocal impact on the prognosis. Validation in a TCGA cohort confirmed these results. Conclusion Our results indicate hsa-miRNA-182-5p and KTN1 as potential biomarkers for OSCC.